Hours

Minutes

Seconds

-40%

on all subscriptions*

Exceptional extension!

Enjoy this offer

* See conditions under "Our services"

Valuation: IMPACT Therapeutics, Inc

Market Cap	8.89B 10.29B 1.31B 1.15B 1.06B 990M 1.86B 124B 1.87B 12.61B 4.9B 60.98B 4.93B 4.82B 212B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	8.06B 9.33B 1.19B 1.04B 961M 897M 1.68B 112B 1.7B 11.43B 4.45B 55.27B 4.47B 4.37B 192B	EV / Sales 2026 *	29x	EV / Sales 2027 *	8.09x
Free-Float	-	Yield 2026 *	-	Yield 2027 *	-

* Estimated data More valuation ratios

Chart: IMPACT Therapeutics, Inc

Timeframe

Style

Dynamic Chart

Latest news : IMPACT Therapeutics, Inc

06-07	Impact Therapeutics Nets HK$120 Million From Full Exercise of IPO Overallotment Option	MT
06-01	Impact Therapeutics, Inc Presents Phase 1/2 Clinical Data for Imp1734 At 2026 Asco Annual Meeting	CI
05-13	Hong Kong Stocks Eke Out Gains; Metis TechBio, Impact Therapeutics Shine on Debut	MT
05-12	Impact Therapeutics Jumps 77% in Hong Kong Trading Debut	MT
05-12	Impact Therapeutics Nets HK$759.5 Million From Hong Kong IPO Ahead of Debut	MT
05-12	IMPACT Therapeutics, Inc has completed an IPO in the amount of HKD 843.7377 million.	CI
05-12	Impact Therapeutics says final offer price under global offering of HK$20.10 per H share	RE
05-05	IMPACT Therapeutics, Inc has filed an IPO in the amount of HKD 913.20964 million.	CI
05-04	IMPACT Therapeutics, Inc Reports Earnings Results for the Full Year Ended December 31, 2025	CI

More news

Managers and Directors: IMPACT Therapeutics, Inc

Manager	Title	Age	Since
Sui Xiong Cai CEO	Chief Executive Officer	69	2014-05-31
Hui Jun Deng DFI	Director of Finance/CFO	51	2024-04-30
Yan Hua Xu CTO	Chief Tech/Sci/R&D Officer	44	2024-12-31

Director	Title	Age	Since
Ye Tian BRD	Director/Board Member	69	2014-05-31
Sui Xiong Cai BRD	Director/Board Member	69	2014-05-31
Ning Ma BRD	Director/Board Member	44	2025-02-28

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMPACT THERAPEUTICS, INC	-2.74%	-3.36%	-	-	1.31B
LONZA GROUP AG	+2.54%	+3.76%	-8.56%	-3.17%	43.24B
REVOLUTION MEDICINES, INC.	+1.73%	+3.59%	+318.08%	+564.04%	35.25B
BEONE MEDICINES AG	+0.61%	+1.34%	+10.00%	+46.20%	30.22B
IQVIA HOLDINGS INC.	+0.02%	-5.93%	+8.45%	-21.44%	28.01B
CELLTRION, INC.	-1.06%	-3.71%	+9.08%	+19.56%	24.08B
ASCENDIS PHARMA A/S	-1.23%	+2.11%	-	-	14.16B
MEDPACE HOLDINGS, INC.	-0.99%	-2.53%	+47.29%	+102.88%	13.01B
EUROFINS SCIENTIFIC SE	+2.39%	+3.57%	+9.14%	+14.81%	12.7B
IONIS PHARMACEUTICALS, INC.	+2.39%	+2.61%	+102.86%	+84.20%	12.54B
Average	+0.35%	-0.14%	+62.04%	+100.88%	21.45B
Weighted average by Cap.	+0.87%	-0.19%	+68.44%	+118.54%

See all sector performances

IMPACT Therapeutics Inc is a China-based company mainly engaged in biotechnology research and commercialization. The Company is in the commercialization stage. The Company is committed to advancing synthetic lethality (SL)-based precision anti-cancer therapies globally. The Company's independently developed core product, senaparib, in China as a 1L maintenance therapy for ovarian cancer (OC). The Company is currently developing product pipeline packages such as PARP1/2, PARP1, ATR, WEE1, PKMYT1/WEE1, DHX9, ATM, USP1, and CHK1/2.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-06-23	HK$36.24	-2.74%	173,200
26-06-22	HK$37.26	+0.70%	357,800
26-06-18	HK$37.00	-1.80%	252,200
26-06-17	HK$37.68	+0.48%	203,400
26-06-16	HK$37.50	+1.68%	188,400

Delayed Quote Hong Kong S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

32.19CNY

Average target price

32.43CNY

Spread / Average Target

+0.74%

Consensus

Net sales - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

1 day	-2.74%
1 week	-3.36%
Current month	-9.17%
1 month	-5.58%

1 week	35.58	37.68
1 month	35	43.08
Current year	28.2	47.98
1 year	28.2	47.98
3 years	28.2	47.98
5 years	28.2	47.98
10 years	28.2	47.98

	2026 *	2027 *
Net sales	278M 321M 40.97M 35.8M 33.12M 30.91M 58.03M 3.87B 58.45M 394M 153M 1.9B 154M 151M 6.61B	941M 1.09B 139M 121M 112M 105M 197M 13.13B 198M 1.33B 519M 6.46B 522M 510M 22.43B
Net income	-	-
Net Debt	-832M -963M -123M -107M -99.32M -92.7M -174M -11.61B -175M -1.18B -459M -5.71B -461M -451M -19.83B	-1.28B -1.48B -189M -165M -152M -142M -267M -17.82B -269M -1.81B -705M -8.76B -708M -693M -30.44B

IMPACT Therapeutics, Inc Stock

Stocks

7630

CNE100007LG4